User profiles for M. Mehta
Minesh MehtaMiami Cancer Institute Verified email at fiu.edu Cited by 69819 |
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future …
…, AB Lassman, E Le Rhun, M Lim, MP Mehta… - Neuro …, 2020 - academic.oup.com
Glioblastomas are the most common form of malignant primary brain tumor and an important
cause of morbidity and mortality. In recent years there have been important advances in …
cause of morbidity and mortality. In recent years there have been important advances in …
Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT …
Resistance to alkylating agents via direct DNA repair by O(6)-methylguanine methyltransferase
(MGMT) remains a significant barrier to the successful treatment of patients with …
(MGMT) remains a significant barrier to the successful treatment of patients with …
Response assessment criteria for brain metastases: proposal from the RANO group
…, DR Macdonald, K Margolin, MP Mehta… - The lancet …, 2015 - thelancet.com
CNS metastases are the most common cause of malignant brain tumours in adults. Historically,
patients with brain metastases have been excluded from most clinical trials, but their …
patients with brain metastases have been excluded from most clinical trials, but their …
[BOOK][B] Random matrices
ML Mehta - 2004 - books.google.com
… For this we divide the interval S into m equal parts. … the probabilities in various intervals
of length S/m obtained by dividing S into m equal parts are mutually independent, we arrive at …
of length S/m obtained by dividing S into m equal parts are mutually independent, we arrive at …
[HTML][HTML] A randomized trial of bevacizumab for newly diagnosed glioblastoma
Background Concurrent treatment with temozolomide and radiotherapy followed by maintenance
temozolomide is the standard of care for patients with newly diagnosed glioblastoma. …
temozolomide is the standard of care for patients with newly diagnosed glioblastoma. …
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 …
…, J Ryu, JP Bahary, L Souhami, M Rotman, MP Mehta… - The Lancet, 2004 - thelancet.com
Background Brain metastases occur in up to 40% of all patients with systemic cancer. We
aimed to assess whether stereotactic radiosurgery provided any therapeutic benefit in a …
aimed to assess whether stereotactic radiosurgery provided any therapeutic benefit in a …
[HTML][HTML] Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
… Employment or Leadership Position: Minesh Mehta, Pharmacyclics (C), Apogenix (C)
Consultant or Advisory Role: John Suh, Abbott (C); Nancy Lin, GlaxoSmithKline (C) …
Consultant or Advisory Role: John Suh, Abbott (C); Nancy Lin, GlaxoSmithKline (C) …
[PDF][PDF] SPRINT: A scalable parallel classifier for data mining
J Shafer, R Agrawal, M Mehta - Vldb, 1996 - cs.ecu.edu
Classi cation is an important data mining problem. Although classi cation is a wellstudied
problem, most of the current classication algorithms require that all or a portion of the the entire …
problem, most of the current classication algorithms require that all or a portion of the the entire …
[HTML][HTML] Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402
… In the PCV arm, four cycles were given every 6 weeks before RT, as follows: lomustine
130 mg/m 2 orally on day 1; procarbazine 75 mg/m 2 orally daily, days 8 through 21; and …
130 mg/m 2 orally on day 1; procarbazine 75 mg/m 2 orally daily, days 8 through 21; and …
SLIQ: A fast scalable classifier for data mining
M Mehta, R Agrawal, J Rissanen - … Avignon, France, March 25–29, 1996 …, 1996 - Springer
… where, cost(DIM) is the cost, in number of bits, of encoding the data given a model M and
cost(M) is the cost of encoding the model M. In the context of the decision tree classifiers, the …
cost(M) is the cost of encoding the model M. In the context of the decision tree classifiers, the …